Hyperactivation of the PI3K/Akt pathway has been associated with resistance against epidermal growth factor receptor (EGFR) inhibitors, as well as enhanced cancer cell invasion and metastasis [72, 73]. The gene discussed is AKT1; the disease is cancer.